Georgia Healthcare Group (GHG) Reaches New 12-Month Low at $214.00

Share on StockTwits

Georgia Healthcare Group PLC (LON:GHG) hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as GBX 214 ($2.76) and last traded at GBX 229 ($2.95), with a volume of 113243 shares trading hands. The stock had previously closed at GBX 222.50 ($2.87).

Several equities research analysts have recently issued reports on the company. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 430 ($5.55) price target on shares of Georgia Healthcare Group in a research report on Wednesday, August 15th. Numis Securities raised Georgia Healthcare Group to a “buy” rating in a research report on Wednesday, August 15th. Finally, Jefferies Financial Group lowered their price target on Georgia Healthcare Group from GBX 400 ($5.16) to GBX 385 ($4.97) and set a “buy” rating on the stock in a research report on Wednesday, May 16th.

In other news, insider Ingeborg Oie bought 7,677 shares of the firm’s stock in a transaction that occurred on Wednesday, June 27th. The shares were acquired at an average cost of GBX 254 ($3.28) per share, with a total value of £19,499.58 ($25,154.26).

About Georgia Healthcare Group (LON:GHG)

Georgia Healthcare Group PLC, together with its subsidiaries, provides healthcare services in Georgia. It operates through Healthcare Services Business, Pharma Business, and Medical Insurance Business segments. As of December 31, 2017, the company operated 16 referral and specialty hospitals comprising 2,519 beds that offer secondary and tertiary level healthcare services; 21 community hospitals, including 495 beds providing basic outpatient and inpatient healthcare services; and 255 pharmacies.

Recommended Story: Asset Allocation Models, Which is Right For You?

Receive News & Ratings for Georgia Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Georgia Healthcare Group and related companies with's FREE daily email newsletter.

Leave a Reply